On ECHEMI
Home > Drugs > Group A and C meningococcal polysaccharide vaccines

Group A and C meningococcal polysaccharide vaccines

Indication

After vaccination, the body can produce humoral immune response. It is used to prevent epidemic cerebrospinal meningitis caused by group A and group C meningococci.

Precautions

1. It is contraindicated for those who are known to be allergic to any component of the vaccine. 2. It is contraindicated for those suffering from acute diseases, severe chronic diseases, acute attacks of chronic diseases and fever. 3. It is contraindicated for those with encephalopathy, uncontrolled epilepsy and other progressive neurological diseases.

Packaging Specification

After reconstitution according to the labeled amount, each bottle (tube) contains 0.5ml, and each human dose is 0.5ml, containing 50μg each of group A and group C polysaccharides.

Manufacturer

Lanzhou Institute of Biological Products Co., Ltd.

  • Founded in:

    1983-04-04
  • Address:

    No. 888, Yanchang Road, Chengguan District, Lanzhou City, Gansu Province
  • Tax NO.:

    916200002243483486
  • Registered Funds:

    1,816.94 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.